跳转至内容
Merck
CN

[Atenolol in treatment of patients with airway obstruction].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego (1996-12-01)
R Chazan
摘要

It is well known that beta-2-blockers are contraindicated for patients with bronchial hyperactivity. Author discusses the clinical observations in relation to treatment with atenolol in circulatory system pathology.

材料
Product Number
品牌
产品描述

Supelco
阿替洛尔标准溶液 溶液, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®